mfresearch ๐Ÿ”’ Show amounts

DSP Small Cap Fund - Direct Plan - Growth

code 119212 Small Cap Fund direct plan ยท growth NAVs 2013-01-02 to 2026-11-09

Benchmark: BSE 250 SMALLCAP (no data) declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2031 (4).xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000

From 2013-01-02. Scroll or drag to zoom.

Drawdown

Rolling 3-year CAGR

Returns

periodfundfrom โ†’ to
1M-0.85% 2026-10-09 โ†’ 2026-11-09
3M-2.06% 2026-08-07 โ†’ 2026-11-09
6M6.30% 2026-05-08 โ†’ 2026-11-09
1Y14.16% 2025-11-07 โ†’ 2026-11-09
3Y15.93% 2023-11-09 โ†’ 2026-11-09
5Y15.73% 2021-11-09 โ†’ 2026-11-09
7Y23.93% 2019-11-08 โ†’ 2026-11-09
10Y16.47% 2016-11-09 โ†’ 2026-11-09
since inception20.90% 2013-01-02 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year.

Calendar years

year201420152016201720182019202020212022202320242025
fund103.13%21.24%13.58%43.38%-25.12%1.62%34.31%60.30%1.37%42.45%26.72%-1.92%

Rolling returns

lengthperiodsaveragemedianworstbest% positive
1 year3,16327.08%19.34% -32.03%125.74%82%
3 years2,67522.15%22.98% -12.56%56.46%93%
5 years2,18020.04%18.94% -0.40%37.68%100%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
5 years
2021-11 โ€“ 2026-10
10 years
2016-11 โ€“ 2026-10
CAGR15.83%16.03%15.56%
volatility21.75%19.37%21.85%
max drawdown-24.14%-24.14%-49.06%
downside deviation13.22%11.74%14.98%
Sharpe ratio0.510.570.53
Sortino ratio0.840.940.77
Calmar ratio0.66--

Category: Small Cap Fund

Overall โ˜…โ˜…โ˜…โ˜†โ˜† (3y โ˜…โ˜…โ˜…โ˜…โ˜† ยท 5y โ˜…โ˜…โ˜…โ˜†โ˜† ยท 10y โ˜…โ˜…โ˜…โ˜†โ˜†) ยท as of 2026-10 ยท 165 months of history

percentile rank (1 = best)3 years
of 24 funds
5 years
of 21 funds
10 years
of 12 funds
return31st35th64th
volatility87th95th73rd
Sharpe35th40th64th
Sortino31st35th64th
worst fall53rd55th73rd
risk-adjusted return (MRAR)31st35th64th

View category โ†’

Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.

Add to comparison โ†’